You are here: Industry Insights > FDA Approval

News List

Weekly Pharma News Review | PharmaSources.com (April 11 to 15) Yefenghong
April 20, 2022
The sharp crushing in the stock prices of Chinese vaccine leader companies Zhifei Biological and Wantai Biological is the most-watched news this week.
Weekly Pharma News Review | PharmaSources.com （April.4th-April.8th） PharmaSources.com
April 12, 2022
This week, the release of Phase III clinical data for treating outpatients infected with mild and moderate COVID-19 with Kintor Pharmaceuticals' proxalutamide sparked an intense interest. The pharma news review of this week covers a total of 18 pieces of
Pfizer, Astellas' Xtandi garners expanded FDA approval to include metastatic castration-sensitive prostate cancer firstwordpharma
December 17, 2019
Pfizer and Astellas announced that the FDA expanded approval of Xtandi (enzalutamide) to include the treatment of patients with metastatic castration-sensitive prostate cancer.
Wontech's Holmium laser receives FDA approval biospectrumasia
September 08, 2019
Holinwon Prima, approved by the FDA, is the first Holmium laser medical device developed in Korea.
Teva Announces FDA approval of AirDuo® Digihaler™ biospectrumasia
July 20, 2019
The First Digital Maintenance Asthma Inhaler Therapy with Integrated Sensors Joins Teva’s Digital Rescue Inhaler Therapy to Provide Patients with Technology to Track Treatment Use
Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease worldpharmanews
February 19, 2019
Novartis announced that the US Food and Drug Administration (FDA) has approved Egaten® (triclabendazole) for the treatment of fascioliasis in patients six years of age and older.
Zydus Cadila gets final US FDA approval to market acne drug expressbpd
January 02, 2019
The drug will be manufactured at the group’s topical manufacturing facility at Ahmedabad
Roche’s lung cancer combo treatment wins FDA approval expressbpd
December 11, 2018
The approval was based on results from a late-stage study, which showed the Tecentriq regimen helped patients with metastatic non-squamous non-small cell lung cancer (NSCLC)
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win fiercepharma
November 16, 2018
AbbVie’s Orilissa (elagolix) snagged its first FDA approval over the summer, and now it’s looking to make it two.
Roche’s Hemlibra secures extended FDA approval for haemophilia A pharmaceutical-technology
October 09, 2018
Roche has secured approval from the US Food and Drug Administration (FDA) for the use of Hemlibra (emicizumab-kxwh) to treat haemophilia A patients without factor VIII inhibitors.

Previous page 1 2 3 Next page